Patent ID: 9707155
Date: 2017-07-18
CPC Classifications: A61J,A61K,B65D,C03C,C07K

Claim:
1. A pharmaceutical product comprising: lixisenatide, alemtuzumab, alirocumab, iniparib, otamixaban, sarilumab, insulin glargine and lixisenatide or semuloparin sodium and a pharmaceutically acceptable excipient; contained within a glass pharmaceutical container comprising a glass composition comprising: SiO alkaline earth oxide comprising both MgO and CaO, wherein CaO is present in an amount up to about 1.0 mol. %, and a ratio (CaO (mol. %)/(CaO (mol. %)+MgO (mol. %))) is less than or equal to 0.5; X mol. % Al Y mol. % alkali oxide, wherein the alkali oxide comprises Na a ratio of a concentration of B